ExamI1:INURSI615/INURS615I(New
Update)IAdvancedI
PharmacotherapeuticsICompleteIGuideIwith
IQsI&IAs|I100%ICorrect|IGradeIAI
(VerifiedIAnswers)-IMaryville
QUESTION
HowIwillIrenalIinsufficiencyIaffectIdrugIelimination?
Answer:
TheIkidneyIisItheIprimaryIorganIofIexcretionIforImostIdrugs.IGeneralIthemeIofImetabolismIisI
toIproduceIdrugImetabolitesIthatIareImoreIwaterIsolubleIandImoreIeasilyIremovedIbyItheIkidn
eys.ITheIrateIatIwhichItheIdrugIisIexcretedIbyItheIkidneysIdependsIonIseveralIfactors.IRenalIb
loodIflowIinfluencesItheIglomerularIfiltrationIrateI(GFR)IwhichIisIhowImuchIplasmaIisIfiltere
dIperIminuteIbyItheIglomerulus.
QUESTION
RenalIexcretionIofIdrugsIisItypicallyIwell-characterized,IwhatIisIvariableIisIthe
Answer:
levelIofIrenalIfunctionItheIpatient.
QUESTION
ItIisIcommonItoImonitorIrenalIfunctionIinIpatientsIbyItheIclinicalIsettingIandItoIadjustIdosages
IbasedIonIrenalIfunction.IThisIisItypicallyIassessedIbyIthe
Answer:
serumIcreatinine.
,QUESTION
PatientsIwithIpoorIrenalIfunctionImayIhaveIhigherIlevelsIofIdrugsIsecondaryIto
Answer:
decreasedIexcretionIofImetabolites.
QUESTION
WhatIisIoff-labelIprescribing?
Answer:
Off-
labelIuseIisItheIuseIofIpharmaceuticalIdrugsIforIanIunapprovedIindicationIorIanIunapprovedIag
eIgroup,IdosageIorIrouteIofIadministration.
QUESTION
WhatIfactorsIplaceIanIinfantIandIchildIatIriskIwhenIprescribingImedication?
Answer:
InIgeneral,IthereIisIaIlackIofIsafetyIandIefficacyIstudiesIinItheIpediatricIpopulationImostImedic
ationsIareIstudiedIinIadultIpopulationsIwhichIbecauseIofIage-
relatedIdifferencesIandImedicationImetabolismIandImechanismsIofIactionIdon'tInecessarilyIapp
lyItoIpediatricIpopulations.IChildrenIareInotIjustIsmallIadults.IAdverseIdrugIreactionsIareImost
IcommonIinIthisIageIgroup.IKidsIdoInotIhaveIaIfullyImatureIliverIandIrenalIfunction,IandIareI
atIhigherIriskIforItoxicityIandIadverseIdrugIeffects.
QUESTION
InIkids,ImedsIshouldIbe
Answer:
,weightIbased.IKidsIdoInotIhaveIaIfullyImatureIliverIandIrenalIfunction,IandIareIatIhigherIriskI
forItoxicityIandIadverseIdrugIeffects.
QUESTION
WhatIADRsIareItheIelderlyIatIriskIofIdeveloping?
Answer:
PhysiologicIchangesIinIolderIadultsIincreaseItheIriskIofIharmIforImedicationImetabolizedIbyIth
eIliverIandIkidneys.
QUESTION
InItheIelderly,IHepaticIbloodIflowIdecreasesIby
Answer:
nearlyIone-halfIorI40%IinIolderIadults.
QUESTION
someIdegreeIofIchronicIkidneyIdiseaseIisIpresentIinIXIofIolderIadult
Answer:
50%
QUESTION
Furthermore,ItheImedianIrenalIbloodIflowIdecreasesIbyIXIbyItheItimeItheIpatientIreachesI80Iy
earsIofIage,IandIx
Answer:
xIofIolderIadultsImaintainInormalIkidneyIfunction/50%,I1/3.IAlthough,ItheInormalIindividualIr
ateIofIdeclineIvariesIandIone-thirdIofIolderIadultsImaintainInormalIrenalIfunction.
, QUESTION
HeartIfailure,IwhichIaffectsImoreIthanIfortyIpercentIofIpersonsIolderIthanI80Iyears,Ican
Answer:
furtherIreduceItheIfunctionIofItheIagingIkidneysIandIliver.
QUESTION
OtherIfactorsIinfluenceIpharmacokineticsIinIolderIadultsIinclude
Answer:
agingIdecreasesIfirst-
passIclearanceIinItheIliver,IandIaInumberIofIcommonlyIprescribedImedicationsIlikeIwarfarin,Ib
enzos,IandIopiatesIrequireImuchIlowerIdosesIinIolderIadults.IDistributionIofIdrugsItoIbodyIco
mpartmentsIhasIchangedIbyItheIdecreaseIinItheIratioIofIleanIbodyIweightItoIbodyIfat.ILevelsI
ofIserumIprotein,IwhichIbindImanyIdrugs,IdecreaseIinIolderIadultsIbecauseIofImalnutritionIand
IdietaryIchangesIthatIareIcommonIforIbothIintentionalIandIunintentionalIregions.IDrugImetabol
ismIcanIbeIaffectedIbyIsubstanceIabuseIincludingIalcohol,IupItoItenIpercentIofIolderIadultsIare
IheavyIorIproblemIdrinkers.IPolypharmacy.
QUESTION
WhatIareItheIadverseIdrugIreactionsIrelatedItoIspecialIpopulations?
Answer:
TheseIcanIcomeIintoItheIcategoriesIofIgenetics,Iage,Igender,IdrugIinteractions,IandImedicalIco
nditions.
QUESTION
TypeI1IhypersensitivityIorIimmediateIhypersensitivityIisIan
Update)IAdvancedI
PharmacotherapeuticsICompleteIGuideIwith
IQsI&IAs|I100%ICorrect|IGradeIAI
(VerifiedIAnswers)-IMaryville
QUESTION
HowIwillIrenalIinsufficiencyIaffectIdrugIelimination?
Answer:
TheIkidneyIisItheIprimaryIorganIofIexcretionIforImostIdrugs.IGeneralIthemeIofImetabolismIisI
toIproduceIdrugImetabolitesIthatIareImoreIwaterIsolubleIandImoreIeasilyIremovedIbyItheIkidn
eys.ITheIrateIatIwhichItheIdrugIisIexcretedIbyItheIkidneysIdependsIonIseveralIfactors.IRenalIb
loodIflowIinfluencesItheIglomerularIfiltrationIrateI(GFR)IwhichIisIhowImuchIplasmaIisIfiltere
dIperIminuteIbyItheIglomerulus.
QUESTION
RenalIexcretionIofIdrugsIisItypicallyIwell-characterized,IwhatIisIvariableIisIthe
Answer:
levelIofIrenalIfunctionItheIpatient.
QUESTION
ItIisIcommonItoImonitorIrenalIfunctionIinIpatientsIbyItheIclinicalIsettingIandItoIadjustIdosages
IbasedIonIrenalIfunction.IThisIisItypicallyIassessedIbyIthe
Answer:
serumIcreatinine.
,QUESTION
PatientsIwithIpoorIrenalIfunctionImayIhaveIhigherIlevelsIofIdrugsIsecondaryIto
Answer:
decreasedIexcretionIofImetabolites.
QUESTION
WhatIisIoff-labelIprescribing?
Answer:
Off-
labelIuseIisItheIuseIofIpharmaceuticalIdrugsIforIanIunapprovedIindicationIorIanIunapprovedIag
eIgroup,IdosageIorIrouteIofIadministration.
QUESTION
WhatIfactorsIplaceIanIinfantIandIchildIatIriskIwhenIprescribingImedication?
Answer:
InIgeneral,IthereIisIaIlackIofIsafetyIandIefficacyIstudiesIinItheIpediatricIpopulationImostImedic
ationsIareIstudiedIinIadultIpopulationsIwhichIbecauseIofIage-
relatedIdifferencesIandImedicationImetabolismIandImechanismsIofIactionIdon'tInecessarilyIapp
lyItoIpediatricIpopulations.IChildrenIareInotIjustIsmallIadults.IAdverseIdrugIreactionsIareImost
IcommonIinIthisIageIgroup.IKidsIdoInotIhaveIaIfullyImatureIliverIandIrenalIfunction,IandIareI
atIhigherIriskIforItoxicityIandIadverseIdrugIeffects.
QUESTION
InIkids,ImedsIshouldIbe
Answer:
,weightIbased.IKidsIdoInotIhaveIaIfullyImatureIliverIandIrenalIfunction,IandIareIatIhigherIriskI
forItoxicityIandIadverseIdrugIeffects.
QUESTION
WhatIADRsIareItheIelderlyIatIriskIofIdeveloping?
Answer:
PhysiologicIchangesIinIolderIadultsIincreaseItheIriskIofIharmIforImedicationImetabolizedIbyIth
eIliverIandIkidneys.
QUESTION
InItheIelderly,IHepaticIbloodIflowIdecreasesIby
Answer:
nearlyIone-halfIorI40%IinIolderIadults.
QUESTION
someIdegreeIofIchronicIkidneyIdiseaseIisIpresentIinIXIofIolderIadult
Answer:
50%
QUESTION
Furthermore,ItheImedianIrenalIbloodIflowIdecreasesIbyIXIbyItheItimeItheIpatientIreachesI80Iy
earsIofIage,IandIx
Answer:
xIofIolderIadultsImaintainInormalIkidneyIfunction/50%,I1/3.IAlthough,ItheInormalIindividualIr
ateIofIdeclineIvariesIandIone-thirdIofIolderIadultsImaintainInormalIrenalIfunction.
, QUESTION
HeartIfailure,IwhichIaffectsImoreIthanIfortyIpercentIofIpersonsIolderIthanI80Iyears,Ican
Answer:
furtherIreduceItheIfunctionIofItheIagingIkidneysIandIliver.
QUESTION
OtherIfactorsIinfluenceIpharmacokineticsIinIolderIadultsIinclude
Answer:
agingIdecreasesIfirst-
passIclearanceIinItheIliver,IandIaInumberIofIcommonlyIprescribedImedicationsIlikeIwarfarin,Ib
enzos,IandIopiatesIrequireImuchIlowerIdosesIinIolderIadults.IDistributionIofIdrugsItoIbodyIco
mpartmentsIhasIchangedIbyItheIdecreaseIinItheIratioIofIleanIbodyIweightItoIbodyIfat.ILevelsI
ofIserumIprotein,IwhichIbindImanyIdrugs,IdecreaseIinIolderIadultsIbecauseIofImalnutritionIand
IdietaryIchangesIthatIareIcommonIforIbothIintentionalIandIunintentionalIregions.IDrugImetabol
ismIcanIbeIaffectedIbyIsubstanceIabuseIincludingIalcohol,IupItoItenIpercentIofIolderIadultsIare
IheavyIorIproblemIdrinkers.IPolypharmacy.
QUESTION
WhatIareItheIadverseIdrugIreactionsIrelatedItoIspecialIpopulations?
Answer:
TheseIcanIcomeIintoItheIcategoriesIofIgenetics,Iage,Igender,IdrugIinteractions,IandImedicalIco
nditions.
QUESTION
TypeI1IhypersensitivityIorIimmediateIhypersensitivityIisIan